Switch to:
More From Other Websites
PDL BioPharma Completes Regular Quarterly Dividend Payment Dec 15 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 15 2014
PDL BioPharma Completes Regular Quarterly Dividend Payment Dec 15 2014
PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties Dec 11 2014
PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million Dec 10 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 10 2014
PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million Dec 10 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Dec 09 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Dec 08 2014
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes Dec 04 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 04 2014
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes Dec 04 2014
PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics Dec 01 2014
PDL BIOPHARMA, INC. Financials Nov 19 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 19 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other... Nov 18 2014
PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics Nov 18 2014
PDL BIOPHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney... Nov 14 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in PDL... Nov 14 2014
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against PDL BioPharma... Nov 14 2014
PDL BIOPHARMA, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other... Nov 14 2014
PDL BioPharma Announces Successful Conclusion of Revenue Interest Agreement with AxoGen Nov 14 2014
PDL BioPharma Announces Successful Conclusion of Revenue Interest Agreement with AxoGen Nov 14 2014
10-Q for PDL BioPharma, Inc. Nov 12 2014
PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference Nov 12 2014
PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference Nov 12 2014
EQUITY ALERT: Rosen Law Firm Reminds PDL BioPharma, Inc. Investors of Important November 17, 2014... Nov 11 2014
PDL BioPharma's Q3 Earnings and Revenues Increase Y/Y Nov 11 2014
PDL BioPharma posts 3Q profit Nov 10 2014
PDL BioPharma Acquires a Portion of the University of Michigan's Royalty Interest in Genzyme's... Nov 06 2014
PDL BioPharma to Announce Third Quarter 2014 Financial Results on November 10, 2014 Nov 03 2014
PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2014 Mar 13 2014
PDL BioPharma Completes Regular Quarterly Dividend Payment Mar 12 2014
PDL BioPharma Provides First Quarter 2014 Revenue Guidance of $133 Million Mar 11 2014
PDL BioPharma Appoints David Gryska to its Board of Directors Mar 10 2014
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes Mar 04 2014
PDL BioPharma Announces Fourth Quarter and Full Year 2013 Financial Results Mar 03 2014
PDL BioPharma to Announce Fourth Quarter and Full Year 2013 Financial Results on March 3, 2014 Feb 24 2014
PDL BioPharma to Present at Upcoming Investor Conferences Feb 19 2014
PDL BioPharma and Paradigm Spine Complete a $75 Million Financing Transaction Feb 18 2014
PDL BioPharma Retains Dr. Stephen Hoffman as Senior Advisor Feb 13 2014
PDL BioPharma Issues $300 Million of Convertible Senior Notes due 2018 Feb 12 2014
PDL BioPharma Prices Offering of $260.87 Million of Convertible Senior Notes Due 2018 Feb 07 2014
PDL Biopharma says it settled Roche royalty fight Feb 03 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK